Mifepristone and Misoprostol are Not “Controlled Dangerous Substances”: The American College of Medical Toxicology Issues Position Statement Phoenix, AZ, Sept. 30, 2024 (GLOBE NEWSWIRE) -- In May of 2024, Louisiana enacted a law classifying mifepristone and misoprostol as Schedule IV controlled dangerous substances, akin to medications...

Medical Abortions Four Times as Risky as Surgical, Reports the Journal of American Physicians and Surgeons TUCSON, Ariz., Dec. 18, 2019 (GLOBE NEWSWIRE) -- Abortion providers are encouraging women to choose the medical abortion option, but studies consistently show that the rate of complications is four...